心血管外科ICU患者输血后SvO₂反应的回顾性观察研究
该单中心回顾性队列研究纳入1352例心血管外科ICU成人患者,均接受1单位红细胞当量输血、输血前Hb≥7.5 g/dL且有配对输血前后SvO₂测量。主要终点为个体水平SvO₂反应(输血开始至约60分钟后ΔSvO₂≥5个百分点)。结果示平均Hb从9.82±0.92升至10.24±0.98 g/dL(配对平均差0.42 g/dL,95%CI 0.38–0.46,P<0.001),而平均SvO₂仅从73.79±9.91%变为73.86±9.37%(配对平均差0.08个百分点,95%CI -0.28–0.43,P=0.671)。输血前SvO₂较低与个体SvO₂反应概率较高相关(校正OR 0.89/每升高1%,95%CI 0.86–0.91,P<0.001),AUC 0.778(95%CI 0.740–0.816),Youden界值69%应视为探索性预测指标而非输血触发值。作者结论强调该关联未确立组织氧合或临床获益。
要点
- 在输血前Hb≥7.5 g/dL的心血管外科ICU成人中,输1单位红细胞当量后群体平均SvO₂几乎不变(73.79%→73.86%,配对平均差0.08个百分点,95%CI -0.28–0.43,P=0.671)。
- 个体水平SvO₂反应(ΔSvO₂≥5个百分点)的概率随输血前SvO₂降低而升高(校正OR 0.89/每升高1%,95%CI 0.86–0.91,P<0.001)。
- 输血前SvO₂对SvO₂反应的判别能力中等(AUC 0.778,95%CI 0.740–0.816),Youden界值69%仅为探索性预测指标,不是输血触发值。
- 平均Hb由9.82±0.92升至10.24±0.98 g/dL(配对平均差0.42 g/dL,95%CI 0.38–0.46,P<0.001),但Hb升高未伴随群体SvO₂的相应升高。
- 作者结论明确:SvO₂升高不必然代表组织氧合改善或临床获益,不支持将SvO₂(包括69%界值)用作输血指征或触发指标。
适用人群与场景
- 成人心血管外科ICU患者,接受1单位红细胞当量输血,输血前Hb≥7.5 g/dL,且有配对输血前和输血后SvO₂测量。
诊断标准与关键阈值
- 个体水平SvO₂反应预设定义为输血开始至约60分钟后ΔSvO₂≥5个百分点。
- 输血前SvO₂预测SvO₂反应的Youden界值为69%,原文明确应解释为急性SvO₂升高的探索性预测指标,而非输血触发值。
研究设计与关键结果
- 单中心回顾性队列研究,1352例独特患者符合最终纳入标准。
- 平均Hb从9.82±0.92升至10.24±0.98 g/dL,配对平均差0.42 g/dL(95%CI 0.38–0.46,P<0.001)。
- 平均SvO₂从73.79±9.91%变为73.86±9.37%,配对平均差0.08个百分点(95%CI -0.28–0.43,P=0.671)。
- 输血前SvO₂较低与个体水平SvO₂反应概率较高相关,多变量logistic回归校正OR 0.89/每升高1%(95%CI 0.86–0.91,P<0.001)。
- 输血前SvO₂对SvO₂反应的判别能力中等,AUC 0.778(95%CI 0.740–0.816),Youden界值69%。
证据类型、等级与局限
- 证据类型:单中心回顾性观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论指出,输血前SvO₂较低与输血后个体SvO₂急性升高相关,但群体平均SvO₂变化极小,该关联未确立组织氧合或临床获益。
- 作者结论明确不支持将SvO₂(包括69%界值)用作输血指征或触发指标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Red blood cell (RBC) transfusion decisions after cardiovascular surgery require integration of hemoglobin (Hb), hemodynamics, bleeding status, and oxygen supply-demand balance. Mixed venous oxygen saturation (SvO₂) reflects the global relationship between oxygen delivery and oxygen consumption, but an increase in SvO₂ does not necessarily indicate improved tissue oxygenation or clinical benefit. We evaluated acute SvO₂ changes after RBC transfusion in cardiovascular surgical ICU patients.
METHODS: We conducted a single-center retrospective cohort study of adult cardiovascular surgical ICU patients who received one RBC-equivalent transfusion with pre-transfusion Hb ≥ 7.5 g/dL and paired pre- and post-transfusion SvO₂ measurements. The primary outcome was an individual-level SvO₂ response, defined a priori as ΔSvO₂ ≥5% points from baseline to approximately 60 min after transfusion initiation. Multivariable regression was used to evaluate predictors selected a priori based on physiologic relevance to oxygen delivery and consumption. Receiver operating characteristic analysis was used to evaluate the discriminative ability of pre-transfusion SvO₂.
RESULTS: 1,352 unique patients met the final inclusion criteria. Mean Hb increased from 9.82 ± 0.92 to 10.24 ± 0.98 g/dL, corresponding to a paired mean difference of 0.42 g/dL (95% CI, 0.38 to 0.46; P < 0.001). Mean SvO₂ changed minimally at the cohort level, from 73.79 ± 9.91% to 73.86 ± 9.37%, corresponding to a paired mean difference of 0.08% points (95% CI, -0.28 to 0.43; P = 0.671). Lower pre-transfusion SvO₂ was associated with a higher probability of an individual-level SvO₂ response. In multivariable logistic regression, pre-transfusion SvO₂ was associated with SvO₂ response (adjusted odds ratio, 0.89 per 1% increase; 95% confidence interval, 0.86-0.91; P < 0.001). Pre-transfusion SvO₂ showed moderate discrimination for SvO₂ response, with an area under the curve of 0.778 (95% confidence interval, 0.740-0.816). The Youden-derived cutoff was 69%, which should be interpreted as an exploratory predictor of acute SvO₂ rise rather than a transfusion trigger.
CONCLUSIONS: Lower pre-transfusion SvO₂ was associated with acute individual-level SvO₂ increase after transfusion, but mean SvO₂ change was minimal. The association did not establish tissue oxygenation or clinical benefit and does not support using SvO₂, including the 69% cutoff, as a transfusion indication or trigger.
参考来源
- Okamoto K, Minami K, Donaldson C, et al. SvO₂ response to red blood cell transfusion in cardiovascular surgical icu patients: a retrospective observational study. Crit Care. 2026. PMID: 42332804. doi:10.1186/s13054-026-06149-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。